RNA Dysfunction and RNA binding Proteins in the Syndrome of ALS/FTD
Journal: Journal of Syndromes (Vol.1, No. 1)Publication Date: 2014-12-30
Authors : Zihui Xu; Shunliang Xu; Yujing Li;
Page : 1-9
Keywords : Amyotrophic Lateral Sclerosis (ALS); Frontotemporal Dementia (FTD); TDP-43; FUS; C9ORF72;
Abstract
RNA dysfunction and abnormal intracellular aggregates comprise a key characteristic in most neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The discoveries with the identification of new genes as major genetic causes of ALS/FTD syndromes reinforce the genetic, clinical and pathological overlap between ALS and FTD. Common causes of these diseases include mutations in the RNA/DNA-binding proteins, TDP-43 and FUS and most recently, GGGGCC hexanucleotide expansions in the C9orf72 gene. TDP-43 and FUS are both RNA processing proteins whose dysfunction impacts on global cellular RNA regulation, and are both abnormally aggregated and mislocalized in ALS and FTD, while The expression of repeat expansions in the C9orf72 gene may induce RNA foci that could sequester RNA binding proteins such as Pur α and hnRNP A3 highlights a further possibly important mechanism of RNA dysfunction in disease. Furthermore, sequestration of key RNA binding proteins may also play an important role in ALS/FTD syndromes due to the association of TDP-43 and FUS with stress granules. In this review we discuss the importance of RNA dysfunction and RNA binding proteins and suggest mechanisms by which they may cause ALS/FTD.
Other Latest Articles
- IPEX Syndrome, FOXP3 and Cancer
- Three Examples Illustrating the Good Performance of an Advanced Mathematical Modeling Method Based on the Theory of Dynamic Systems in Pharmacokinetics
- The Role of Protein S-Nitrosylationin Alzheimer’s Disease and its Treatment
- NMDA Receptor Antagonism by Phencyclidine Reduces NWASP and WAVE1 Protein Expression and Reduces Levels of Myelination Markers in the Prefrontal Cortex of Rats
- Another Example of a Successful Use of Computational and Modeling Tools from the Theory of Dynamic Systems in Pharmacokinetic Modeling
Last modified: 2016-12-22 15:49:47